Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Incyte

Incyte launches award programme recognising innovation in GVHD community

Incyte launches award programme recognising innovation in GVHD community

have a devastating impact on the lives of patients,” said Barry Flannelly, executive vice president and general manager, US, Incyte. ... Through the Incyte Ingenuity Award, we hope to spark creativity and innovation, which we expect to result in

Incyte’s JAK inhibitor cream clears second eczema trial

Incyte’s JAK inhibitor cream clears second eczema trial Set for regulatory filings later this year. Incyte now has a pair of positive phase 3 trials for its topical formulation of JAK1/2 inhibitor ruxolitinib in atopic dermatitis or eczema, ... Incyte has said it intends to market ruxolitinib cream itself in

Novartis pulls ahead of Merck in MET-positive lung cancer race

Novartis pulls ahead of Merck in MET-positive lung cancer race Capmatinib – originally developed by Incyte and licensed to Novartis in 2009 – has been submitted for approval in the US for metastatic MET exon14 skipping-mutated NSCLC, a form of lung cancer

Incyte signs lymphoma deal worth up to $1.1bn with MorphoSys

Incyte signs lymphoma deal worth up to $1.1bn with MorphoSys to patients and the clinical community around the world,” said Hervé Hoppenot, CEO of Incyte. ... Under the terms of the deal, Incyte is paying MorphoSys $750m upfront, as well as making an equity investment worth $150m in the company.

Incyte claims FDA priority review for bile duct cancer drug

Incyte claims FDA priority review for bile duct cancer drug Significant need for new therapies in hard-to-treat cancer type. Incyte’s new drug pemigatinib has been given a priority review for a rare type of bile duct cancer by ... Incyte says cholangiocarcinoma affects between 0.3 – 3.4 people per 100, 000 in

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Virtual Engagement At Porterhouse: Reflections on the past few months
...
July 2020: diversity and inclusion in clinical trials round-up
COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
Medical Device Clinical Trials 2020
In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...

Infographics